• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION VALVE CONTEGRA; CONDUIT,VALVED,PULMONIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION VALVE CONTEGRA; CONDUIT,VALVED,PULMONIC Back to Search Results
Model Number CONTEGRA
Device Problem Calcified (1077)
Patient Problems Ossification (1428); Autoimmune Reaction (1733); Stenosis (2263)
Event Date 01/01/2012
Event Type  Injury  
Manufacturer Narrative
Citation: holmes a et al.The contegra conduit: late outcomes in right ventricular outflow tract reconstruction.Ann pediatr cardiol.2012 jan-jun; 5(1): 27¿33.Doi: 10.4103/0974-2069.93706 earliest date of publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.(b)(4).A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding clinical outcomes and performance of the contegra conduit as a right ventricle outflow tract implant.All data were collected from a single center between january 2002 and june 2009.The study population included 45 patients (predominantly male; mean age 4 years) all which were implanted with a medtronic contegra conduit (serial numbers not provided).Among all patients 3 deaths occurred; none of the deaths were attributed to medtronic product.Among all patients there were 9 conduit related surgical interventions (5 due to conduit stenosis and 4 due to distal stenosis).Of 8 conduit explants, all eight were found to have partially or fully calcified valve leaflets and fibrotic tissue in the supravalvular region, all eight had evidence of epithelioid giant cell immune response to foreign bodies, and three were noted with sites of ossification.No additional adverse patient effects were reported.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALVE CONTEGRA
Type of Device
CONDUIT,VALVED,PULMONIC
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key6439797
MDR Text Key71039442
Report Number2025587-2017-00495
Device Sequence Number1
Product Code MWH
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
H020003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/27/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberCONTEGRA
Device Catalogue NumberCONTEGRA
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/27/2017
Initial Date FDA Received03/28/2017
Supplement Dates Manufacturer Received02/27/2017
Supplement Dates FDA Received10/02/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age4 YR
-
-